PBYI logo

Puma Biotechnology (PBYI) EBITDA

Annual EBITDA

$47.52 M
+$25.63 M+117.11%

December 31, 2023

Summary

Performance

1-Year Change

+117.11%

3-Year Change

+233.08%

5-Year Change

+149.92%

15-Year Change

+116.48%

PBYI EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

85.2%
PBYI annual EBITDA is higher than 85.2% of companies in Healthcare sector

High & Low

All-time High

$47.52 M
PBYI annual EBITDA is currently at an all-time high

3-Year Low

-$4.69 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
PBYI previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
PBYI next annual earnings announcement is scheduled for Feb 28, 2025

OtherPBYIprofitabilitymetrics:

Annual Revenue

$235.64 M
PBYI annual revenue is $235.64 million

Annual Net Income

$21.59 M
PBYI annual net profit is $21.59 million

Annual EBIT

$36.00 M
PBYI annual earnings before interest & taxes is $36.00 million

Annual EPS

$0.45
PBYI annual earnings per share is $0.45

Quarterly EBITDA

$26.59 M
+$24.46 M+1148.76%

September 30, 2024

Summary

Performance

3-Month Change

+1148.76%

1-Year Change

+117.49%

3-Year Change

+82.21%

5-Year Change

+82.21%

PBYI Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

85.51%
PBYI quarterly EBITDA is higher than 85.51% of companies in Healthcare sector

High & Low

All-time High

$26.59 M
PBYI quarterly EBITDA is currently at an all-time high

3-Year Low

$420.00 K
PBYI quarterly EBITDA is currently +6230.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PBYI previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
PBYI next earnings announcement is scheduled for Feb 28, 2025

OtherPBYIprofitabilitymetrics:

Quarterly Revenue

$80.54 M
PBYI quarterly revenue is $80.54 million

Quarterly Net Income

$20.32 M
PBYI quarterly net profit is $20.32 million

Quarterly EBIT

$23.71 M
PBYI quarterly earnings before interest & taxes is $23.71 million

Quarterly EPS

$0.41
PBYI quarterly earnings per share is $0.41

TTM EBITDA

$49.42 M
+$14.36 M+40.96%

September 30, 2024

Summary

Performance

3-Month Change

+40.96%

1-Year Change

+71.04%

3-Year Change

+492.4%

5-Year Change

+492.4%

PBYI TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

83.81%
PBYI TTM EBITDA is higher than 83.81% of companies in Healthcare sector

High & Low

All-time High

$49.42 M
PBYI TTM EBITDA is currently at an all-time high

3-Year Low

-$25.80 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PBYI previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
PBYI next earnings announcement is scheduled for Feb 28, 2025

OtherPBYIprofitabilitymetrics:

TTM Revenue

$243.57 M
PBYI TTM revenue is $243.57 million

TTM Net Income

$23.24 M
PBYI TTM net profit is $23.24 million

TTM EBIT

$37.85 M
PBYI TTM earnings before interest & taxes is $37.85 million

TTM EPS

$0.47
PBYI TTM earnings per share is $0.47

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$47.52 M
PBYI annual EBITDA is $47.52 million

Annual Net Income

$21.59 M
PBYI annual net profit is $21.59 million

Annual Interest Expense

$13.33 M
PBYI annual interest expense is $13.33 million

Annual Income Tax

$1.08 M
PBYI annual income tax is $1.08 million

Annual D&A

$11.52 M
PBYI annual depreciation & amortization is $11.52 million

PBYI EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+117.1%+117.5%+71.0%
3 y3 years+233.1%+82.2%+492.4%
5 y5 years+149.9%+82.2%+492.4%

PBYI EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+1113.3%at high+6230.0%at high+291.6%
5 y5-yearat high+190.6%at high+168.0%at high+181.2%
alltimeall timeat high+116.5%at high+134.3%at high+116.6%

Puma Biotechnology EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
$26.59 M(+1148.8%)
$49.42 M(+41.0%)
Jun 2024
-
$2.13 M(+28.2%)
$35.06 M(-15.4%)
Mar 2024
-
$1.66 M(-91.3%)
$41.45 M(-12.8%)
Dec 2023
$47.52 M(+117.1%)
$19.05 M(+55.8%)
$47.52 M(+64.5%)
Sep 2023
-
$12.22 M(+43.6%)
$28.90 M(+32.6%)
Jun 2023
-
$8.51 M(+10.0%)
$21.80 M(-21.8%)
Mar 2023
-
$7.74 M(+1742.4%)
$27.87 M(+27.3%)
Dec 2022
$21.89 M(-566.7%)
$420.00 K(-91.8%)
$21.89 M(-30.7%)
Sep 2022
-
$5.12 M(-64.9%)
$31.60 M(-350.9%)
Jun 2022
-
$14.59 M(+731.4%)
-$12.60 M(-51.2%)
Mar 2022
-
$1.75 M(-82.7%)
-$25.80 M(+462.2%)
Dec 2021
-$4.69 M(-86.9%)
$10.13 M(-125.9%)
-$4.59 M(-80.0%)
Sep 2021
-
-$39.07 M(-2921.2%)
-$22.99 M(+160.6%)
Jun 2021
-
$1.39 M(-94.0%)
-$8.82 M(+1012.7%)
Mar 2021
-
$22.97 M(-377.6%)
-$793.00 K(-97.8%)
Dec 2020
-$35.71 M(-31.9%)
-$8.27 M(-66.8%)
-$35.71 M(+6.3%)
Sep 2020
-
-$24.90 M(-364.5%)
-$33.61 M(+63.2%)
Jun 2020
-
$9.42 M(-178.8%)
-$20.59 M(-66.2%)
Mar 2020
-
-$11.95 M(+93.6%)
-$60.89 M(+16.1%)
Dec 2019
-$52.45 M(-44.9%)
-$6.17 M(-48.1%)
-$52.45 M(-26.2%)
Sep 2019
-
-$11.89 M(-61.5%)
-$71.03 M(+4.8%)
Jun 2019
-
-$30.88 M(+779.9%)
-$67.78 M(-11.7%)
Mar 2019
-
-$3.51 M(-85.8%)
-$76.77 M(-19.3%)
Dec 2018
-$95.19 M(-67.0%)
-$24.75 M(+186.3%)
-$95.19 M(-28.1%)
Sep 2018
-
-$8.65 M(-78.3%)
-$132.44 M(-33.8%)
Jun 2018
-
-$39.87 M(+81.8%)
-$200.07 M(-15.9%)
Mar 2018
-
-$21.93 M(-64.6%)
-$237.76 M(-17.6%)
Dec 2017
-$288.42 M(+4.9%)
-$62.00 M(-18.7%)
-$288.42 M(-3.3%)
Sep 2017
-
-$76.28 M(-1.6%)
-$298.13 M(+3.6%)
Jun 2017
-
-$77.56 M(+6.8%)
-$287.74 M(+4.1%)
Mar 2017
-
-$72.59 M(+1.2%)
-$276.41 M(+0.6%)
Dec 2016
-$274.86 M
-$71.70 M(+8.8%)
-$274.86 M(+4.1%)
Sep 2016
-
-$65.89 M(-0.5%)
-$263.99 M(+2.1%)
DateAnnualQuarterlyTTM
Jun 2016
-
-$66.23 M(-6.8%)
-$258.64 M(+0.6%)
Mar 2016
-
-$71.04 M(+16.8%)
-$257.13 M(+7.8%)
Dec 2015
-$238.51 M(+68.4%)
-$60.83 M(+0.5%)
-$238.51 M(+6.0%)
Sep 2015
-
-$60.53 M(-6.5%)
-$225.08 M(+12.3%)
Jun 2015
-
-$64.72 M(+23.5%)
-$200.35 M(+14.9%)
Mar 2015
-
-$52.42 M(+10.6%)
-$174.38 M(+23.1%)
Dec 2014
-$141.65 M(+160.3%)
-$47.40 M(+32.4%)
-$141.65 M(+28.6%)
Sep 2014
-
-$35.80 M(-7.6%)
-$110.11 M(+24.4%)
Jun 2014
-
-$38.76 M(+96.9%)
-$88.53 M(+41.9%)
Mar 2014
-
-$19.69 M(+24.1%)
-$62.38 M(+14.6%)
Dec 2013
-$54.41 M(-26.7%)
-$15.86 M(+11.5%)
-$54.41 M(-9.9%)
Sep 2013
-
-$14.22 M(+12.8%)
-$60.41 M(-16.1%)
Jun 2013
-
-$12.61 M(+7.6%)
-$72.00 M(-2.8%)
Mar 2013
-
-$11.72 M(-46.4%)
-$74.10 M(-0.1%)
Dec 2012
-$74.19 M(+631.2%)
-$21.87 M(-15.2%)
-$74.18 M(+19.5%)
Sep 2012
-
-$25.80 M(+75.4%)
-$62.09 M(+69.6%)
Jun 2012
-
-$14.71 M(+24.6%)
-$36.62 M(+66.9%)
Mar 2012
-
-$11.80 M(+20.8%)
-$21.95 M(+116.3%)
Dec 2011
-$10.15 M(>+9900.0%)
-$9.77 M(+2828.2%)
-$10.15 M(+2653.3%)
Sep 2011
-
-$333.80 K(+878.9%)
-$368.50 K(+872.3%)
Jun 2011
-
-$34.10 K(+774.4%)
-$37.90 K(+511.3%)
Mar 2011
-
-$3900.00(-218.2%)
-$6200.00(-11.4%)
Dec 2010
-$7000.00(-58.3%)
$3300.00(-203.1%)
-$7000.00(-48.5%)
Sep 2010
-
-$3200.00(+33.3%)
-$13.60 K(-0.7%)
Jun 2010
-
-$2400.00(-48.9%)
-$13.70 K(-11.6%)
Mar 2010
-
-$4700.00(+42.4%)
-$15.50 K(-7.7%)
Dec 2009
-$16.80 K(+19.1%)
-$3300.00(0.0%)
-$16.80 K(+7.0%)
Sep 2009
-
-$3300.00(-21.4%)
-$15.70 K(-4.3%)
Jun 2009
-
-$4200.00(-30.0%)
-$16.40 K(+5.1%)
Mar 2009
-
-$6000.00(+172.7%)
-$15.60 K(+10.6%)
Dec 2008
-$14.10 K
-$2200.00(-45.0%)
-$14.10 K(+18.5%)
Sep 2008
-
-$4000.00(+17.6%)
-$11.90 K(+50.6%)
Jun 2008
-
-$3400.00(-24.4%)
-$7900.00(+75.6%)
Mar 2008
-
-$4500.00
-$4500.00

FAQ

  • What is Puma Biotechnology annual EBITDA?
  • What is the all time high annual EBITDA for Puma Biotechnology?
  • What is Puma Biotechnology annual EBITDA year-on-year change?
  • What is Puma Biotechnology quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Puma Biotechnology?
  • What is Puma Biotechnology quarterly EBITDA year-on-year change?
  • What is Puma Biotechnology TTM EBITDA?
  • What is the all time high TTM EBITDA for Puma Biotechnology?
  • What is Puma Biotechnology TTM EBITDA year-on-year change?

What is Puma Biotechnology annual EBITDA?

The current annual EBITDA of PBYI is $47.52 M

What is the all time high annual EBITDA for Puma Biotechnology?

Puma Biotechnology all-time high annual EBITDA is $47.52 M

What is Puma Biotechnology annual EBITDA year-on-year change?

Over the past year, PBYI annual EBITDA has changed by +$25.63 M (+117.11%)

What is Puma Biotechnology quarterly EBITDA?

The current quarterly EBITDA of PBYI is $26.59 M

What is the all time high quarterly EBITDA for Puma Biotechnology?

Puma Biotechnology all-time high quarterly EBITDA is $26.59 M

What is Puma Biotechnology quarterly EBITDA year-on-year change?

Over the past year, PBYI quarterly EBITDA has changed by +$14.36 M (+117.49%)

What is Puma Biotechnology TTM EBITDA?

The current TTM EBITDA of PBYI is $49.42 M

What is the all time high TTM EBITDA for Puma Biotechnology?

Puma Biotechnology all-time high TTM EBITDA is $49.42 M

What is Puma Biotechnology TTM EBITDA year-on-year change?

Over the past year, PBYI TTM EBITDA has changed by +$20.53 M (+71.04%)